Bio-Rad Laboratories, Inc.
BIO · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$342 | -$120 | $64 | -$716 |
| Dep. & Amort. | $54 | -$38 | $38 | $49 |
| Deferred Tax | -$88 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | -$15 | $15 | $16 |
| Change in WC | -$14 | -$44 | $44 | $57 |
| Other Non-Cash | $511 | $334 | -$31 | $717 |
| Operating Cash Flow | $121 | $117 | $130 | $124 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$32 | -$46 | -$34 | -$43 |
| Net Acquisitions | $0 | -$217 | $0 | $0 |
| Inv. Purchases | -$224 | -$153 | -$153 | -$223 |
| Inv. Sales/Matur. | $214 | $300 | $191 | $235 |
| Other Inv. Act. | -$2 | $0 | $0 | -$0 |
| Investing Cash Flow | -$43 | -$115 | $3 | -$31 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | -$0 |
| Stock Issued | $3 | $4 | $0 | $0 |
| Stock Repurch. | -$53 | -$140 | -$102 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | -$0 | $4 | -$26 |
| Financing Cash Flow | -$53 | -$136 | -$98 | -$26 |
| Forex Effect | $1 | -$16 | -$2 | $10 |
| Net Chg. in Cash | $27 | -$151 | $33 | $78 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $372 | $523 | $490 | $412 |
| End Cash | $398 | $372 | $523 | $490 |
| Free Cash Flow | $89 | $71 | $96 | $81 |